These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32084472)

  • 1. Functional and structural characterization of an ecotin-like serine protease inhibitor from Trypanosoma cruzi.
    Garcia FB; Cabral AD; Fuhlendorf MM; da Cruz GF; Dos Santos JV; Ferreira GC; de Rezende BRC; Santana CM; Puzer L; Sasaki SD; Garcia W; Sperança MA
    Int J Biol Macromol; 2020 May; 151():459-466. PubMed ID: 32084472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ecotin-like peptidase inhibitor of Trypanosoma cruzi prevents TMPRSS2-PAR2-TLR4 crosstalk downmodulating infection and inflammation.
    Costa TFR; Catta-Preta CMC; Goundry A; Carvalho DB; Rodrigues NS; Vivarini AC; de Abreu MF; Reis FCG; Lima APCA
    FASEB J; 2024 Mar; 38(6):e23566. PubMed ID: 38526868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease.
    de Almeida Nogueira NP; Morgado-Díaz JA; Menna-Barreto RF; Paes MC; da Silva-López RE
    Acta Trop; 2013 Oct; 128(1):27-35. PubMed ID: 23770204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinases of Trypanosoma cruzi: patential targets for the chemotherapy of Changas desease.
    Cazzulo JJ
    Curr Top Med Chem; 2002 Nov; 2(11):1261-71. PubMed ID: 12171584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
    Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
    J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi.
    Joyeau R; Maoulida C; Guillet C; Frappier F; Teixeira AR; Schrével J; Santana J; Grellier P
    Eur J Med Chem; 2000 Feb; 35(2):257-66. PubMed ID: 10758287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major.
    Eschenlauer SC; Faria MS; Morrison LS; Bland N; Ribeiro-Gomes FL; DosReis GA; Coombs GH; Lima AP; Mottram JC
    Cell Microbiol; 2009 Jan; 11(1):106-20. PubMed ID: 19016791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening.
    de Almeida H; Leroux V; Motta FN; Grellier P; Maigret B; Santana JM; Bastos IM
    J Comput Aided Mol Des; 2016 Dec; 30(12):1165-1174. PubMed ID: 27770305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
    Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
    Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
    Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi.
    Freymann DM; Wenck MA; Engel JC; Feng J; Focia PJ; Eakin AE; Craig SP
    Chem Biol; 2000 Dec; 7(12):957-68. PubMed ID: 11137818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
    Maluf FV; Andricopulo AD; Oliva G; Guido RV
    Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter.
    Sayé M; Fargnoli L; Reigada C; Labadie GR; Pereira CA
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2913-2921. PubMed ID: 28844978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the inhibition of human and Trypanosoma cruzi prolyl endopeptidases.
    Vendeville S; Goossens F; Debreu-Fontaine MA; Landry V; Davioud-Charvet E; Grellier P; Scharpe S; Sergheraert C
    Bioorg Med Chem; 2002 Jun; 10(6):1719-29. PubMed ID: 11937331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of chagas' disease: an overview.
    Paulino M; Iribarne F; Dubin M; Aguilera-Morales S; Tapia O; Stoppani AO
    Mini Rev Med Chem; 2005 May; 5(5):499-519. PubMed ID: 15892691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.